Arena Pharmaceuticals announced the pricing of a public offering Dec. 8 for 11.5 million shares of common stock at $13.21 per share.
Underwriters for the offering have the option to purchase an additional 1.7 million shares to cover over-allotments.
Arena stock’s trading volume Dec. 8 at 10:30 a.m. was at 2.3 million.
San Diego-based bio-pharmaceutical company Arena is traded on the Nasdaq as ARNA and closed Dec. 7 at $13.21, down 23 cents from the previous day’s close.
, Andy Killion